Insider buying
~$5M562K sh @ $8.90
Traded Oct 30, 2024 · filed 2 days later
A major shareholder of Engene Therapeutics paid $5M out of pocket for Engene Therapeutics shares. Shares held went up 23% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 29, 2023 · Filed Oct 18, 2024
A major shareholder of Engene Therapeutics paid $87K out of pocket for Engene Therapeutics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$87,451
Shares × reported transaction price
$25K–$100K
+0.5%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 2 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
31 days before results of Jan 29, 2024
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −10.1% | −0.5% | −9.6% |
| 30 days | −23.7% | +1.2% | −24.9% |
| 90 days | −29.1% | +3.3% | −32.4% |
| 180 days | −59.4% | −11.9% | −47.5% |
| 365 days | −13.5% | +15.0% | −28.6% |
Past results only. Not a forecast.
Insider buying
Traded Oct 30, 2024 · filed 2 days later
A major shareholder of Engene Therapeutics paid $5M out of pocket for Engene Therapeutics shares. Shares held went up 23% with this purchase.
Insider buying
Traded Dec 27, 2023 · filed 296 days later
A major shareholder of Engene Therapeutics paid $20K out of pocket for Engene Therapeutics shares.
Insider buying
Traded Dec 28, 2023 · filed 295 days later
A major shareholder of Engene Therapeutics paid $39K out of pocket for Engene Therapeutics shares.